Co-Founder and Director of Medical and Scientific Affairs | Westbridge Clinical Ltd

Dr. Chidi A. Udoeze is a physician and clinical research professional with multidisciplinary experience spanning clinical medicine, infectious diseases, clinical research, advanced cellular immunotherapy, and biopharmaceutical manufacturing.

He previously served as a Study Physician and Research Clinician with Health Initiatives for Safety and Stability in Africa (HIFASS), contributing to the African Cohort Study (RV 329), a collaborative research initiative involving the Nigerian Ministry of Defence Health Implementation Program and the United States Department of Defense Walter Reed Program Nigeria. His clinical experience also includes the management of infectious diseases, particularly HIV and tuberculosis, at the 45 Nigerian Air Force Hospital.

In the United States, Dr. Udoeze gained hands-on experience in advanced cellular immunotherapy manufacturing at Lonza Cell and Gene Therapy in Houston, Texas. His work involved manufacturing processes supporting chimeric antigen receptor T-cell (CAR-T) therapies within current Good Manufacturing Practice (cGMP) regulated environments. This experience strengthened his understanding of cellular processing, quality systems, and the complex manufacturing requirements of innovative cancer immunotherapies.

Dr. Udoeze has contributed to peer-reviewed medical literature covering the neurological manifestations of lysosomal storage diseases, risk stratification and management of arrhythmias in Wolff-Parkinson-White syndrome, and diagnostic approaches to glomerular diseases. His research background also includes undergraduate public health research involving questionnaire-based primary data collection, reflecting an early commitment to evidence-based medicine and population health.

As Co-Founder and Director of Medical and Scientific Affairs at Westbridge Clinical Ltd, Dr. Udoeze brings together clinical expertise, research experience, and an understanding of regulated biopharmaceutical processes to advance the company’s commitment to scientifically rigorous, ethical, and high-quality clinical research.

Selected Publications

1. Neurological Manifestations of Lysosomal Storage Diseases Annals of Medicine and Surgery, 2024. DOI: doi.org/10.1097/MS9.0000000000002611

2. Risk Stratification and Management of Arrhythmias in Patients with Wolff-Parkinson-White Syndrome Annals of Medicine and Surgery, 2025. DOI: doi.org/10.1097/MS9.0000000000003068

3. Diagnostic Approach to Glomerular Diseases International Journal of Surgery: Global Health, 2025. DOI: doi.org/10.1097/GH9.0000000000000529